0,932  0,005  Apoptosis agonist
0,908  0,003  Chemopreventive
0,886  0,006  Antiinflammatory
0,869  0,004  Chemoprotective
0,854  0,010  Transcription factor NF kappa B inhibitor
0,837  0,006  Caspase 9 stimulant
0,805  0,004  Nitric oxide antagonist
0,785  0,001  Cholesterol synthesis inhibitor
0,772  0,011  Antineoplastic (lung cancer)
0,755  0,005  Hepatic disorders treatment
0,731  0,004  Apoptosis antagonist
0,717  0,004  UGT1A4 substrate
0,688  0,006  NOS3 expression inhibitor
0,670  0,004  Hepatoprotectant
0,669  0,006  Antineoplastic (pancreatic cancer)
0,658  0,013  Antihypercholesterolemic
0,649  0,008  AR expression inhibitor
0,634  0,011  Bone diseases treatment
0,636  0,014  Cholesterol antagonist
0,627  0,011  Antineoplastic (melanoma)
0,618  0,009  Lipoprotein disorders treatment
0,620  0,022  Antileukemic
0,611  0,015  Antineoplastic (ovarian cancer)
0,626  0,031  Antineoplastic (breast cancer)
0,582  0,014  Cytotoxic
0,581  0,012  Antiosteoporotic
0,580  0,028  TNF expression inhibitor
0,562  0,013  Caspase 3 stimulant
0,564  0,018  Sensitization
0,543  0,003  Antiinfertility, female
0,537  0,003  DNA polymerase I inhibitor
0,541  0,015  Antifungal
0,532  0,009  Antineoplastic (lymphoma)
0,539  0,026  Prostate cancer treatment
0,521  0,008  UGT2B4 substrate
0,536  0,024  Immunosuppressant
0,529  0,017  Proliferative diseases treatment
0,515  0,004  Antifungal enhancer
0,522  0,020  Antineoplastic (cervical cancer)
0,531  0,029  Teratogen
0,530  0,033  Antibacterial
0,512  0,030  Embryotoxic
0,485  0,004  Sodium/bile acid cotransporter inhibitor
0,486  0,008  Antiviral (Herpes)
0,487  0,012  Antineoplastic (endocrine cancer)
0,492  0,020  Antineoplastic (glioma)
0,477  0,008  Prostatic (benign) hyperplasia treatment
0,476  0,008  Hair growth stimulant
0,484  0,018  Antiprotozoal (Leishmania)
0,477  0,011  Antineoplastic (liver cancer)
0,491  0,029  CYP2C19 substrate
0,464  0,007  Prostate disorders treatment
0,462  0,007  Antiacne
0,469  0,021  Antineoplastic (multiple myeloma)
0,454  0,007  UGT2B7 substrate
0,498  0,051  Cyclophilin D inhibitor
0,498  0,051  Antidiabetic
0,465  0,024  Antioxidant
0,439  0,010  Contraceptive
0,436  0,014  UGT1A1 substrate
0,468  0,047  CYP3A4 substrate
0,442  0,025  NOS2 expression inhibitor
0,406  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,404  0,003  Alcohol dehydrogenase substrate
0,408  0,010  Interferon gamma antagonist
0,411  0,022  Antihypoxic
0,434  0,046  Antineoplastic (colorectal cancer)
0,438  0,054  Antiprotozoal
0,391  0,009  Protein-tyrosine phosphatase inhibitor
0,413  0,035  ICAM1 expression inhibitor
0,401  0,025  Hypolipemic
0,421  0,046  Antineoplastic (colon cancer)
0,419  0,045  Antiprotozoal (Plasmodium)
0,408  0,039  Antipsoriatic
0,378  0,010  Lipocortins synthesis antagonist
0,371  0,009  Antiviral (Influenza A)
0,394  0,033  Carcinogenic
0,372  0,022  Wound healing agent
0,394  0,051  Immunostimulant
0,345  0,004  CDC25B inhibitor
0,341  0,020  Antiviral (Influenza)
0,346  0,026  Abortion inducer
0,363  0,048  Antineoplastic (brain cancer)
0,347  0,034  Vascular (periferal) disease treatment
0,317  0,005  Farnesoid X receptor antagonist
0,305  0,003  5-Alpha-reductase inhibitor
0,330  0,029  UDP-glucuronosyltransferase substrate
0,302  0,005  Anticataract
0,339  0,042  Renal disease treatment
0,332  0,039  Antineoplastic (glioblastoma multiforme)
0,328  0,039  Angiogenesis stimulant
0,335  0,050  Hypoxia-inducible factor 1 alpha inhibitor
0,341  0,059  Respiratory analeptic
0,293  0,015  Phospholipase A2 inhibitor
0,281  0,004  Aldehyde dehydrogenase substrate
0,360  0,084  Atherosclerosis treatment
0,274  0,005  Inducible nitric-oxide synthase inhibitor
0,290  0,023  Melanin inhibitor
0,285  0,024  Antineoplastic (squamous cell carcinoma)
0,264  0,004  CDC25A inhibitor
0,282  0,024  UGT1A3 substrate
0,262  0,005  ABCA1 expression enhancer
0,348  0,092  Antipruritic, allergic
0,299  0,052  Antineoplastic (renal cancer)
0,309  0,067  Interleukin 2 agonist
0,268  0,029  Antipruritic, non-allergic
0,282  0,044  Antihypertriglyceridemic
0,239  0,004  Ca(v)3.1 blocker
0,286  0,058  Hypoglycemic
0,253  0,028  Skin irritative effect
0,233  0,010  Arachidonic acid antagonist
0,248  0,029  Amylase inhibitor
0,271  0,056  Gastrin inhibitor
0,263  0,048  Antiviral (HIV)
0,240  0,026  LDLR expression enhancer
0,312  0,098  Stroke treatment
0,237  0,024  UGT2B9 substrate
0,238  0,028  Skin whitener
0,220  0,011  Contraceptive female
0,271  0,072  UGT1A9 substrate
0,214  0,019  Antineoplastic antibiotic
0,216  0,025  Aldose reductase substrate
0,189  0,013  TRPA1 agonist
0,179  0,003  Na+ K+ transporting ATPase inhibitor
0,268  0,095  Analeptic
0,171  0,008  Lipase inhibitor
0,231  0,069  Antiulcerative
0,202  0,041  Lipid peroxidase inhibitor
0,167  0,006  3C-Like protease (SARS coronavirus) inhibitor
0,203  0,043  Antineoplastic (carcinoma)
0,224  0,068  Antineoplastic enhancer
0,172  0,017  Androgen antagonist
0,246  0,093  Antidiabetic (type 2)
0,194  0,042  UGT2B10 substrate
0,161  0,013  Anabolic
0,221  0,078  UGT1A6 substrate
0,173  0,031  Antihemorrhagic
0,203  0,062  P-glycoprotein inhibitor
0,166  0,030  Pregnane X receptor agonist
0,150  0,016  Transcription factor NF kappa B stimulant
0,131  0,004  Heme oxygenase stimulant
0,149  0,023  Nitric-oxide synthase inhibitor
0,162  0,040  Antiviral (Hepatitis B)
0,139  0,022  Antiviral (Coronavirus)
0,139  0,022  Antiviral (SARS coronavirus)
0,171  0,063  Interleukin 6 antagonist
0,185  0,079  Platelet adhesion inhibitor
0,109  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,108  0,005  5-Alpha-reductase 2 inhibitor
0,121  0,019  Bile acid receptor antagonist
0,107  0,007  Liver X receptor agonist
0,124  0,025  Antiviral (Rhinovirus)
0,102  0,004  5-Alpha-reductase 1 inhibitor
0,107  0,010  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,165  0,068  Eye irritation, high
0,123  0,028  Lanosterol 14 alpha demethylase inhibitor
0,113  0,018  HIV-1 integrase (Strand Transfer) inhibitor
0,127  0,032  Factor V inhibitor
0,201  0,108  Tumour necrosis factor alpha release inhibitor
0,279  0,187  Alzheimer's disease treatment
0,249  0,158  Antiobesity
0,119  0,035  UGT2B11 substrate
0,180  0,096  Insulin sensitizer
0,093  0,009  Aldosterone antagonist
0,146  0,064  Anesthetic
0,087  0,005  Farnesoid X receptor agonist
0,125  0,046  Estrogen antagonist
0,144  0,064  Bone formation stimulant
0,088  0,009  Lipocortins synthesis agonist
0,116  0,037  Estrogen receptor beta antagonist
0,220  0,144  CTGF expression inhibitor
0,075  0,009  RNA-directed RNA polymerase stimulant
0,117  0,055  Choleretic
0,080  0,019  Hypercalcemia treatment
0,093  0,032  Estrogen receptor alpha antagonist
0,065  0,006  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,067  0,010  Liver X receptor alpha agonist
0,174  0,120  Free radical scavenger
0,132  0,078  Neurotrophic factor
0,065  0,014  Estrogen receptor alpha agonist
0,098  0,048  Actinic keratosis treatment
0,052  0,004  Vitamin D receptor antagonist
0,076  0,030  Aromatase inhibitor
0,057  0,012  Glucocorticoid antagonist
0,150  0,107  Phospholipase C inhibitor
0,056  0,014  Parathyroid hormone antagonist
0,093  0,053  Ornithine decarboxylase inhibitor
0,149  0,110  Antihelmintic
0,047  0,009  HMG CoA reductase inhibitor
0,140  0,104  Liver fibrosis treatment
0,103  0,067  UGT2B1 substrate
0,131  0,098  Mutagenic
0,123  0,089  Protein kinase stimulant
0,080  0,047  Antibiotic
0,097  0,064  Dementia treatment
0,063  0,030  Postmenopausal disorders treatment
0,095  0,062  Vascular dementia treatment
0,082  0,051  Topoisomerase II alpha inhibitor
0,075  0,045  Glycine receptor agonist
0,072  0,044  Anticholelithogenic
0,047  0,020  Estrogen receptor beta agonist
0,155  0,130  Neurotrophic factor enhancer
0,057  0,032  Estrogen agonist
0,105  0,081  Microtubule formation inhibitor
0,051  0,029  Mineralocorticoid receptor antagonist
0,041  0,020  Glucose-6-phosphate dehydrogenase inhibitor
0,055  0,034  Acetyl-CoA transferase inhibitor
0,032  0,011  1,3-Beta-glucan synthase inhibitor
0,124  0,105  Antidiabetic (type 1)
0,122  0,103  Diuretic
0,059  0,042  Androgen agonist
0,116  0,101  UGT2B15 substrate
0,027  0,012  CYP24 inhibitor
0,154  0,140  Antineoplastic (lymphocytic leukemia)
0,100  0,086  Topoisomerase II inhibitor
0,076  0,064  Glycine receptor antagonist
0,083  0,073  Paget's disease treatment
0,015  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,022  0,013  Corticosteroid-like
0,078  0,068  Thioredoxin reductase inhibitor
0,146  0,138  Antiparasitic
0,156  0,150  Acute neurologic disorders treatment
0,057  0,052  Antimycoplasmal
0,017  0,013  Progesterone agonist
0,047  0,044  Protein 50S ribosomal subunit inhibitor
0,165  0,163  RNA-directed DNA polymerase inhibitor
0,017  0,016  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,025  0,024  Retinoid X gamma receptor antagonist

